OPEN Health

OPEN Health combines market access, HEOR, medical affairs, scientific communications, and creative services. Its evidence work supports value, access, reimbursement, and decision-making beyond clinical trials, while its communications work translates complex clinical data for healthcare audiences.

Market Access and Evidence Decisions

• Plan HTA and reimbursement evidence with HTA strategy and submissions, HEOR strategy and evidence planning, and market access guidance. The firm translates evidence into value communication for reimbursement and access decisions.
• Build evidence for access and HEOR using real-world evidence on disease burden, treatment patterns, effectiveness, and costs; economic models and comparative analyses support clinical and economic value. Outcomes research addresses burden of illness and patient-relevant outcomes.

Scientific Communications and Congresses

• Build evidence foundations and integrated publication strategies that address scientific gaps and maximize the impact of data across the lifecycle. Scientific communications turn complex science into clear narratives and content for audiences across channels.
• Shape congress strategy that combines competitive intelligence, scientific engagement, and real-time insight generation. Congress intelligence includes live tracking and post-event synthesis to support decisions about what matters next.

Medical Affairs and Expert Engagement

• Set Medical Affairs priorities and plans by bringing together evidence, field intelligence, stakeholder perspectives, and emerging signals, from assessing the evidence landscape to identifying gaps. Scientific communications strategy builds evidence-based scientific narratives designed to stay coherent across channels and stakeholders.
• Identify and engage external experts through KOL mapping, scientific exchange, and stakeholder engagement. OPEN Health also provides advisory board services and speaker program management, including an integrated speaker bureau.

Insights, Creative, and Portfolio Strategy

• Generate market and patient insights through HCP insight synthesis and patient experience research that informs strategy, education, and publishable experiences.
• Develop creative campaigns that turn complex science and strategy into visual, designed, and animated content for clinical, access, and commercial moments. Portfolio and asset strategy considers connections across therapy areas and portfolios.

Best Fit

• Life-sciences teams planning HTA submissions, reimbursement evidence, real-world evidence, or health economic models.
• Medical affairs, commercial, and communications teams needing publication planning, congress support, expert engagement, promotional medical education, or patient and consumer engagement programs.